Acrux Health Care
Biotech Healthcare North America Pharmaceuticals

$0.042 -0.001 (-2.33%)

High $0.04	Low $0.04	Trades 17	Turnover $24,861	Volume 582,113
30 June 2023 at 3:56pm

Please note that we source our information from many sources. The below may not be accurate, or up to date. Please bear with us whilst we fine tune our data collection. In the meantime, we do not recommend relying on the below. It is merely a guide!

Stock Information

Code ACR	Name ACRUX Ltd	Country AU	Currency AUD
GIC Sector Health Care	GIC Group Pharmaceuticals, Biotechnology & Life Sciences	GIC Industry Pharmaceuticals	GIC Sub Industry Pharmaceuticals
Sector Healthcare	IPO Date N/A	Fiscal Year June	Type Common Stock
Shares Outstanding 589,677,802	Shares Floated 308,367,005	Held by Insiders 16.647%	Held by Institutions 7.769%

Directors & Officers

Name & Education	Position
Mr. John Warmbrunn	MD, CEO & Director
Ms. Joanna Johnson B.E., BEc, ICAA	CFO & Company Secretary
Ms. Felicia Colagrande B.Sc., BSc (Hons), M.B.A.	Product Development & Technical Affairs Director
Mr. Mark Hyman	Project & Technical Development Director

ACR Historic Dividends

Date	Amount
18 August 2015	$0.06000
4 September 2014	$0.08000
25 February 2014	$0.12000
3 September 2013	$0.08000
4 September 2012	$0.08000
31 March 2011	$0.60000

End of Day Prices

Date	Close	Volume	Change
31-Jul	$0.01	62,766	0.00 (0.00%)
30-Jul	$0.01	3,698,957	0.00 (9.09%)
29-Jul	$0.01	1,429,995	0.00 (0.00%)
28-Jul	$0.01	2,638,948	0.00 (0.00%)
27-Jul	$0.01	169,956	0.00 (8.33%)
24-Jul	$0.01	30,408	0.00 (0.00%)
23-Jul	$0.01	111,592	0.00 (0.00%)
22-Jul	$0.01	339	0.00 (0.00%)
21-Jul	$0.01	700,000	0.00 (0.00%)
20-Jul	$0.01	250,000	0.00 (0.00%)
17-Jul	$0.01	0	0.00 (14.29%)
18-Sep	$0.01	621,724	0.00 (3.45%)
12-Sep	$0.01	0	0.00 (0.00%)
11-Sep	$0.01	13,113	+0.00 (3.57%)
05-Sep	$0.01	209,502	0.00 (0.00%)
1 up, 4 down, and 10 flat days

Market Cap (31-Jul) $5,239,089	EBITDA -	PE 11.60	Book Value $0.00
Dividend per Share N/A	Dividend Yield N/A	EPS $-0.01	Profit Margin N/A
Operating Margin -102.3%	ROA 57.22%	ROE 102.19%	Revenue (FY) $2,810,000
Revenue per Share $0.01	Gross Profit (FY) $1,281,000	Q' YOY Revenue Growth 1350%	Q' YOY Earnings Growth -

Acrux Health Care
Biotech Healthcare North America Pharmaceuticals

Stock Information

Technicals

Financial Snapshot (December 2025)

Directors & Officers

ACR Historic Dividends

Followers

Prices

Announcements

End of Day Prices

ACR Acrux Health Care Biotech Healthcare North America Pharmaceuticals

Stock Information

Technicals

Financial Snapshot (December 2025)

Directors & Officers

ACR Historic Dividends

Followers

Prices

Announcements

End of Day Prices

Acrux Health Care
Biotech Healthcare North America Pharmaceuticals